1-8 of 8
Aaron E. Foster, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Development of Inducible MyD88/CD40 (iMC)-Enhanced Chimeric Antigen Receptor Natural Killer (GoCAR-NK) Cells to Target BCMA + Tumors

Xiaomei Wang, PhD, MyLinh T Duong, PhD, Alan D. Guerrero, PhD, Aruna Mahendravada, MS, Kelly L Sharp, BS, Mary E. Brandt, BS, Christine Gagliardi, PhD, Aaron E. Foster, PhD, J. Henri Bayle, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-140848
Published: 2020
Journal Articles

Inducible MyD88/CD40 (iMC) Enhances Proliferation and Survival of Tumor-Specific TCR-Modified T Cells and Improves Anti-Tumor Efficacy in Myeloma

Tsvetelina Pentcheva-Hoang, PhD, David Torres, Tania Rodriguez, PhD, Ana Korngold, PhD, An Lu, Jeannette Crisostomo, Annemarie Moseley, MD PhD, Lorenz Jahn, Mirjam H.M. Heemskerk, PhD, Kevin M Slawin, MD, David M Spencer, PhD, Aaron E Foster, PhD
Journal: Blood
Blood (2016) 128 (22): 4550.
https://doi.org/10.1182/blood.V128.22.4550.4550
Published: 2016
Journal Articles

Inducible MyD88/CD40 (iMC) Costimulation Provides Ligand-Dependent Tumor Eradication By CD123-Specific Chimeric Antigen Receptor T Cells

Aaron E Foster, PhD, MyLinh Duong, PhD, An Lu, Peter Chang, PhD, Aruna Mahendravada, Nicholas Shinners, PhD, Kevin M Slawin, MD, J. Henri Bayle, PhD, David M Spencer, PhD
Journal: Blood
Blood (2016) 128 (22): 4551.
https://doi.org/10.1182/blood.V128.22.4551.4551
Published: 2016
Journal Articles

Vaccination with ΔCD40L or Flagellin Gene-Modified T Cells Activates Dendritic Cells In Vivo and Induces a Potent Anti-Tumor Immune Response

Adham S Bear, Meghan M Turnis, PhD, Xiao-Tong Song, PhD, Russell Cruz, MD, An Lu, Stephen Gottschalk, MD, Cliona M Rooney, PhD, Aaron E Foster, PhD
Journal: Blood
Blood (2011) 118 (21): 1909.
https://doi.org/10.1182/blood.V118.21.1909.1909
Published: 2011
Journal Articles

Safely Improving the in Vivo Survival of Tumor Specific Cytotoxic T Lymphocytes by Co-Transfer of IL7 Receptor Alpha Chain and icaspase9

Juan F Vera, MD, Valentina Hoyos, MD, Barbara Savoldo, MD, Concetta Quintarelli, PhD, Greta A Giordano, Ann M. Leen, PhD, Hao Liu, Aaron E. Foster, PhD, Helen E. Heslop, MD, Cliona M Rooney, PhD, Malcolm K Brenner, MD, PhD, Gianpietro Dotti, MD
Journal: Blood
Blood (2008) 112 (11): 3534.
https://doi.org/10.1182/blood.V112.11.3534.3534
Published: 2008
Journal Articles

Immune Responses Are Induced Against Side-Population B-CLL “Stem Cells ” by Patient Vaccination with hCD40L/IL2 Gene Modified Tumor Cells.

Aaron E. Foster, PhD, Gianpietro Dotti, MD, An Lu, Michael Andreeff, MD, Margaret Goodell, PhD, Cliona M. Rooney, PhD, Malcolm K. Brenner, MD
Journal: Blood
Blood (2006) 108 (11): 2552.
https://doi.org/10.1182/blood.V108.11.2552.2552
Published: 2006
Journal Articles

IL-21 Gene Modified T Antigen Presenting Cells Enhance the Generation of Tumor-Specific Cytotoxic T Lymphocytes with a Memory Phenotype.

Anjum S. Kaka, MD, Ryan Hartmeier, Ann M. Leen, PhD, An Lu, Cliona M. Rooney, PhD, Aaron E. Foster, PhD
Journal: Blood
Blood (2006) 108 (11): 3709.
https://doi.org/10.1182/blood.V108.11.3709.3709
Published: 2006
Journal Articles

Ex-Vivo Expansion and Prophylactic Infusion of CMV pp65 Specific CTL Following Haemopoietic Stem Cell Transplantation (HSCT).

David J. Gottlieb, MD, FRACP, Anna M. Hansen, PhD, Ken P. Micklethwaite, MB, Aaron E. Foster, PhD, Cameron J. Turtle, MB PhD FRACP, Vicki Antonenas, MSc, Mary M. Sartor, MSc, Ken F. Bradstock, MB PhD FRACP
Journal: Blood
Blood (2005) 106 (11): 3244.
https://doi.org/10.1182/blood.V106.11.3244.3244
Published: 2005